Details for New Drug Application (NDA): 022534
✉ Email this page to a colleague
The generic ingredient in DOCETAXEL is docetaxel. There are forty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the docetaxel profile page.
Pharmacology for NDA: 022534
Physiological Effect | Microtubule Inhibition |
Suppliers and Packaging for NDA: 022534
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DOCEFREZ | docetaxel | INJECTABLE;INJECTION | 022534 | NDA | Sun Pharmaceutical Industries, Inc. | 47335-323 | 47335-323-40 | 1 VIAL, GLASS in 1 CARTON (47335-323-40) / 1 mL in 1 VIAL, GLASS |
DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 022534 | NDA | Sun Pharmaceutical Industries, Inc. | 47335-323 | 47335-323-40 | 1 VIAL, GLASS in 1 CARTON (47335-323-40) / 1 mL in 1 VIAL, GLASS |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/VIAL | ||||
Approval Date: | May 3, 2011 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 80MG/VIAL | ||||
Approval Date: | May 3, 2011 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/ML (20MG/ML) | ||||
Approval Date: | Jan 8, 2019 | TE: | AP | RLD: | No |
Complete Access Available with Subscription